selected scholarly activity
-
chapters
- Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin for Surgery. 124-130. 2008
- Hormone replacement therapy and venous thromboembolism: Risks, mechanisms, and patient management. 454-464. 2006
- Oral contraceptive use and venous thromboembolism: Epidemiology, mechanisms, and patient management. 413-422. 2006
-
conferences
- Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study. Blood. 90-90. 2016
- Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery. Blood. 1130-1130. 2015
- Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism. Blood. 2015
- Perioperative management of dabigatran: a prospective cohort study. Journal of Thrombosis and Haemostasis. 203-203. 2015
- Case fatality of antithrombotic therapy associated major bleeding or major trauma. Journal of Thrombosis and Haemostasis. 417-417. 2013
- Development and accreditation of a standardized training program in thrombosis and vascular medicine - a Canadian initiative. Journal of Thrombosis and Haemostasis. 602-602. 2013
- Efficacy and safety of weight-adjusted extended duration tinzaparin for prevention of post-operative venous thromboembolism after bariatric surgery. Journal of Thrombosis and Haemostasis. 821-821. 2013
- External validation and updating of the Vienna Prediction Model for recurrent venous thromboembolism using a pooled individual patient data database. Journal of Thrombosis and Haemostasis. 879-880. 2013
- The prognostic significance of residual vein obstruction in patients with treated deep vein thrombosis: a patient-level meta-analysis. Journal of Thrombosis and Haemostasis. 339-339. 2013
- Positive Predictive Value of Progressively Elevated D-Dimer Levels in Patients with a Suspected First Deep Vein Thrombosis.. Blood. 2258-2258. 2012
- C0306 Accuracy of emergency physician’ performed ultrasonography in the diagnosis of deep vein thrombosis: A systematic review and a meta-analysis of the literature. Thrombosis Research. S197-S197. 2012
- Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score. Blood. 251-252. 2011
- Venous Thromboembolism Validation Study of the IMPROVE Risk Assessment Models in the Medical Patient (VTE-VALOURR). Blood. 1803-1804. 2011
- Can the CHADS2 score predict postoperative stroke risk in patients with chronic atrial fibrillation who are having elective non-cardiac surgery?. Journal of Thrombosis and Haemostasis. 635-635. 2011
- Perioperative heparin bridging in patients receiving oral anticoagulation: meta-analysis of bleeding and thromboembolic rates. Journal of Thrombosis and Haemostasis. 604-604. 2011
- Venous thromboembolism validation study of the improve risk assessment models in the medical patient (VTE-VALOURR). Journal of Thrombosis and Haemostasis. 402-403. 2011
- Safety of Excluding Suspected Deep Vein Thrombosis with a Single Whole-Leg Compression Ultrasound: Systematic Review and Meta-Analysis. Blood. 104-105. 2009
- Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. Journal of Thrombosis and Thrombolysis. 96-96. 2008
- Is statin therapy associated with a decreased risk for bleeding in patients with chronic atrial fibrillation who are receiving warfarin? A population-based nested case-control study. Pharmacoepidemiology and Drug Safety. S47-S47. 2006
- Does thromboprophylaxis reduce mortality in medical patients? A systematic review and meta-analysis of randomized controlled tials. Blood. 266A-266A. 2005
- Should high-risk patients with chronic atrial fibrillation and those with coronary artery disease receive combined aspirin-oral anticoagulant therapy or oral anticoagulant therapy alone? A systematic review and meta-analysis. Blood. 265A-266A. 2005
- Enoxaparin Is Effective and Safe as Bridging Anticoagulation in Patients with a Mechanical Prosthetic Heart Valve who Require Temporary Interruption of Warfarin because of Surgery or an Invasive Procedure.. Blood. 703-703. 2004
- Risk Factors for Bleeding in Patients with Nonvalvular Atrial Fibrillation Who Are Receiving Anticoagulant Therapy with Ximelagatran or Warfarin: Findings from the SPORTIF III and V Trials.. Blood. 528-528. 2004
- Ximelagatran Versus Warfarin: A Comparison of Bleeding Outcomes in Patients with Nonvalvular Atrial Fibrillation.. Blood. 1765-1765. 2004
- Incidence of Smith-Lemli-Opitz syndrome in Canada: results of a 36 month surveillance program.. Genetics in Medicine. 306-306. 2004
- Are brand-name and generic warfarin interchangeable?. Clinical Pharmacology and Therapeutics. P27-P27. 2004
- A randomized trial of two intensities of warfarin (international normalized ratio of 2.0 to 3.0 versus 3.1 to 4.0) for the prevention of recurrent thrombosis in patients with antiphospholipid antibodies.. Blood. 148A-148A. 2002
- Case-fatality for major bleeding and intracranial hemorrhage in patients with venous thromboembolism on long-term oral anticoagulant therapy: A systematic review.. Blood. 705A-705A. 2002
- Employing a validated assessment tool to evaluate interactions of warfarin with drugs and food.. Clinical Pharmacology and Therapeutics. P23-P23. 2002
- Treatment of excessive anticoagulation due to warfarin with oral vitamin K: A randomized controlled trial.. Blood. 450A-450A. 2000
- ESTROGEN THERAPY AND THE RISK OF VENOUS THROMBOEMBOLISM - A REEVALUATION. Thrombosis and Haemostasis. 951-951. 1995
- THE EFFECTS OF LONG-TERM HEPARIN ON BONE-DENSITY - A PROSPECTIVE CASE-CONTROL STUDY. Thrombosis and Haemostasis. 1302-1302. 1995
-
journal articles
- Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review. Thrombosis and Haemostasis. 124:1040-1052. 2024
- Temporal Trends in the Management Practices of Clinically Important Perioperative Atrial Fibrillation After Noncardiac Surgery.. CJC OPEN. 6:1363-1371. 2024
- Perioperative Management of Patients Taking Direct Oral Anticoagulants. Journal of the American Medical Association (JAMA). 332:825-834. 2024
- Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial. Journal of Stroke and Cerebrovascular Diseases. 33:107839-107839. 2024
- Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper. Thrombosis and Haemostasis. 124:770-777. 2024
- How to undertake procedures while on antiplatelet agents: a hematologist's view.. Research and Practice in Thrombosis and Haemostasis. 8:102539. 2024
- Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial. Journal of Thrombosis and Haemostasis. 22:2227-2233. 2024
- Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by one stage assays with prothrombin time versus Ecarin reagents. Journal of Thrombosis and Haemostasis. 22:3059-3069. 2024
- Removing cross-cultural barriers to participation in the ISTH Congress. Journal of Thrombosis and Haemostasis. 22:1803-1805. 2024
- Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 22:2889-2899. 2024
- Perioperative Management of Antithrombotic Therapy in Patients Undergoing Plastic and Reconstructive Surgery: A Practical Tool Based on Current Guidelines. Plastic Surgery. 22925503241256654. 2024
- Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trial. BMJ Open. 14:e079353-e079353. 2024
- Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?. European Journal of Internal Medicine. 122:40-41. 2024
- Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer. Journal of Thrombosis and Haemostasis. 22:727-737. 2024
- Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure. Blood Advances. 8:732-735. 2024
- In medical inpatients, the IMPROVE risk score had moderate predictive power for 14-d in-hospital bleeding. ACP journal club. 177:JC11-JC11. 2024
- Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry. Journal of Thrombosis and Haemostasis. 21:3581-3588. 2023
- Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. 21:3649-3657. 2023
- In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level. ACP journal club. 176:JC91-JC91. 2023
- Routine measurement of DOAC concentrations for prognostication and clinical management in acute ischemic stroke: Is it ready for prime time?. European Journal of Internal Medicine. 113:18-19. 2023
- Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020 – ADDENDUM. Canadian Journal of Neurological Sciences. 50:481-481. 2023
- Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants. Chest. 163:1245-1257. 2023
- Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy. American Journal of Gastroenterology. 118:812-819. 2023
- Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. Journal of Thrombosis and Haemostasis. 21:933-943. 2023
- Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review. Research and Practice in Thrombosis and Haemostasis. 7:100137-100137. 2023
- Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. Journal of Thoracic and Cardiovascular Surgery. 165:794-824.e6. 2023
- The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score’s functional disability component. Research and Practice in Thrombosis and Haemostasis. 7:100051-100051. 2023
- Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. 8:847-856. 2022
- Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. European Journal of Cardio-thoracic Surgery. 63:ezac488. 2022
- Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. Journal of Thrombosis and Haemostasis. 20:2953-2963. 2022
- Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial. Pilot and Feasibility Studies. 8:166. 2022
- Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 20:3026-3038. 2022
- Executive Summary. Chest. 162:1127-1139. 2022
- Perioperative Management of Antithrombotic Therapy. Chest. 162:e207-e243. 2022
- Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials. Journal of Clinical Medicine. 11:5997-5997. 2022
- Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 20:2226-2236. 2022
-
Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and
meta‐analysis . British Journal of Haematology. 199:130-142. 2022 - 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. The Lancet Oncology. 23:e334-e347. 2022
- Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients. Clinical and Translational Science. 15:1687-1697. 2022
- The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis. JMV-Journal de Medecine Vasculaire. 47:113-115. 2022
- Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020. Canadian Journal of Neurological Sciences. 49:315-337. 2022
- American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period. American Journal of Gastroenterology. 117:542-558. 2022
- American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period. Journal of the Canadian Association of Gastroenterology. 5:100-101. 2022
- Management of Patients on Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Peri-Endoscopic Period: A Clinical Practice Guideline Dissemination Tool. American Journal of Gastroenterology. 117:513-519. 2022
- Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?. European Journal of Internal Medicine. 96:13-16. 2022
- Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort. Research and Practice in Thrombosis and Haemostasis. 6:e12650-e12650. 2022
- Perioperative management of antithrombotic therapy: a case-based narrative review. Internal and emergency medicine. 17:25-35. 2022
- Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials. Journal of Clinical Medicine. 10:5366-5366. 2021
- Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home. Thrombosis Research. 206:18-28. 2021
- Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey. British Journal of Anaesthesia. 127:e143-e145. 2021
- Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery. Postgraduate Medicine. 133:20-26. 2021
- The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper. Thrombosis and Haemostasis. 121:992-1007. 2021
- Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thrombosis Research. 202:176-181. 2021
- Postoperative atrial fibrillation after non-cardiac surgery: How important is it and what do we do about it?. European Journal of Internal Medicine. 85:25-26. 2021
- Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E304-E309. 2021
- Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more. Thrombosis Research. 198:1-6. 2021
- A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant. Research and Practice in Thrombosis and Haemostasis. 5:159-167. 2021
- Double Blind Pilot Randomized Trial Comparing Extended Anticoagulation to Placebo Following Major Lung Resection for Cancer. Seminars in Thoracic and Cardiovascular Surgery. 33:1123-1134. 2021
- Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health‐care providers. Journal of Thrombosis and Haemostasis. 19:153-160. 2021
- Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 18:3174-3183. 2020
- Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines. World Journal of Urology. 38:2761-2770. 2020
- Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. Journal of the American Heart Association. 9:e017316. 2020
- Recommandations canadiennes pour les pratiques optimales de soins de l’AVC, septième édition : l’acide acétylsalicylique pour la prévention d’événements vasculaires. CANADIAN MEDICAL ASSOCIATION JOURNAL. 192:E1174-E1184. 2020
- Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol. BMJ Open. 10:e036537-e036537. 2020
- Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Advances. 4:3520-3527. 2020
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19. Journal of Thrombosis and Haemostasis. 18:1859-1865. 2020
- Evidence-based medicine and COVID-19: human important outcome measures. Making decisions under conditions of uncertainty. Polskie Archiwum Medycyny Wewnetrznej. 130:714-715. 2020
- Periprocedural Management of Oral Anticoagulation. Medical Clinics of North America. 104:709-726. 2020
- Thrombolysis in Pulmonary Embolism. Critical Care Clinics. 36:465-480. 2020
- The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants. American Journal of Emergency Medicine. 38:1163-1170. 2020
- International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis. European Journal of Cardio-thoracic Surgery. 57:854-859. 2020
- Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. Research and Practice in Thrombosis and Haemostasis. 4:562-568. 2020
- Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events. CANADIAN MEDICAL ASSOCIATION JOURNAL. 192:E302-E311. 2020
- Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant—Reply. JAMA Internal Medicine. 180:333-333. 2020
- Prevention of venous thromboembolism in medical cancer patients: Guidance or guideline?. Journal of Thrombosis and Haemostasis. 18:520-521. 2020
- Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. European Heart Journal. 41:645-651. 2020
- Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey. European Journal of Cardio-thoracic Surgery. 57:331-337. 2020
- Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis. Research and Practice in Thrombosis and Haemostasis. 4:131-140. 2020
- Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. ACP journal club. 171:805-805. 2019
- 2019 international clinical practice guidelines for the treatment of venous thromboembolism – Authors' reply. The Lancet Oncology. 20:e656-e656. 2019
- Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients. Thrombosis Journal. 17:24. 2019
- Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill. Thrombosis Journal. 17:6. 2019
- Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with Postthrombotic Syndrome. Thrombosis and Haemostasis. 119:1897-1899. 2019
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Internal Medicine. 179:1469-1469. 2019
- Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk. Journal of Thrombosis and Haemostasis. 17:1966-1972. 2019
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. The Lancet Oncology. 20:e566-e581. 2019
- Structure and function of a perioperative anticoagulation management clinic. Thrombosis Research. 182:167-174. 2019
- An assay to measure levels of factor Xa inhibitors in blood and plasma. Journal of Thrombosis and Haemostasis. 17:1153-1159. 2019
- Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study. Journal of Thrombosis and Haemostasis. 17:1144-1152. 2019
- Periprocedural interruption of anticoagulation in patients with cancer‐associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes. Journal of Thrombosis and Haemostasis. 17:1171-1178. 2019
- Pulmonary embolism: update on diagnosis and management. Medical Journal of Australia. 211:82-87. 2019
- In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days. ACP journal club. 170:JC67-JC67. 2019
- Deep vein thrombosis: update on diagnosis and management. Medical Journal of Australia. 210:516-524. 2019
- Prevalence of antiphospholipid antibodies among patients with chronic thromboembolic pulmonary hypertension. Internal and emergency medicine. 14:495-496. 2019
- Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials. BMJ Open. 9:e024444-e024444. 2019
- A Device on Trial — Intermittent Pneumatic Compression in Critical Care. New England Journal of Medicine. 380:1367-1368. 2019
- Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016–2017. Internal and emergency medicine. 14:355-363. 2019
- Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly. Thrombosis Research. 174:148-150. 2019
- Perioperative management of patients who are receiving antiplatelet therapy: a case-based, evidence-informed approach. Polskie Archiwum Medycyny Wewnetrznej. 128:771-778. 2018
- Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non–vitamin K Anticoagulant Reversal. Anesthesiology. 129:1171-1184. 2018
- Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time. Thrombosis Research. 171:62-67. 2018
- A clinical conundrum: to measure or not measure direct oral anticoagulants before a surgery or procedure?. Internal and emergency medicine. 13:997-999. 2018
- Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery. Journal of Thrombosis and Haemostasis. 16:2008-2015. 2018
- Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness. New England Journal of Medicine. 379:1118-1127. 2018
- Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 118:1679-1680. 2018
- Perioperative management of anticoagulant and antiplatelet therapy. Heart. 104:1461-1467. 2018
- Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. The Lancet. 391:2325-2334. 2018
- Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial. Thrombosis and Haemostasis. 118:1001-1008. 2018
- Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 131:2151-2160. 2018
- An opinion on the benefits of concomitant oral contraceptive therapy in premenopausal women treated with oral anticoagulants. Thrombosis Research. 165:14-17. 2018
- Reversal agents for non-vitamin K antagonist oral anticoagulants. Nature Reviews Cardiology. 15:273-281. 2018
- Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Clinical Respiratory Journal. 2018:CD008201. 2018
- Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta‐analysis. Research and Practice in Thrombosis and Haemostasis. 2:282-290. 2018
- 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy. Canadian Journal of Cardiology. 34:214-233. 2018
- A pharmacist checklist for direct oral anticoagulant management: Raising the bar. Canadian Pharmacists Journal. 151:102-106. 2018
- Age‐adjusted D‐dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm. Journal of Thrombosis and Haemostasis. 16:271-278. 2018
- Age-adjusted D-dimer value for the diagnosis of deep vein thrombosis - Results of the PALLADIO algorithm. Vasomed. 30:290-291. 2018
- Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial. PLoS ONE. 13:e0198285-e0198285. 2018
- Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial. American Heart Journal. 195:108-114. 2018
- Bridge Therapy Outcomes in Patients With Mechanical Heart Valves. Clinical and Applied Thrombosis/Hemostasis. 23:1036-1041. 2017
- Navigating the anticoagulant landscape in 2017. Cleveland Clinic Journal of Medicine. 84:768-778. 2017
- Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. Europace. 19:1630-1636. 2017
- Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy. Journal of the American Heart Association. 6:e006015. 2017
- Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials. Journal of Thrombosis and Thrombolysis. 43:291-301. 2017
- Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism. Thrombosis Research. 151:67-71. 2017
- Managing challenging patients with venous thromboembolism: a practical, case-based approach. Polskie Archiwum Medycyny Wewnetrznej. 127:41-46. 2017
- Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey. Journal of Thoracic Disease. 9:80-87. 2017
- Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens. Thrombosis and Haemostasis. 117:382-389. 2017
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 117:2415-2424. 2017
- Perioperative Aspirin for Prevention of Venous Thromboembolism. Anesthesiology. 125:1121-1129. 2016
- Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?. Internal and emergency medicine. 11:1037-1040. 2016
- The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal. Internal and emergency medicine. 11:1031-1035. 2016
- To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment. Journal of Thrombosis and Haemostasis. 14:2556-2559. 2016
- Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests Reply. Regional Anesthesia and Pain Medicine. 41:788-788. 2016
- BRIDGE trial. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 1. Polskie Archiwum Medycyny Wewnetrznej. 126:798-800. 2016
- Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2. Polskie Archiwum Medycyny Wewnetrznej. 126:801-802. 2016
- D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment. Thrombosis Research. 146:119-125. 2016
- International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. The Lancet Oncology. 17:e452-e466. 2016
- Perioperative Management of the Direct Oral Anticoagulants. Hematology/Oncology Clinics of North America. 30:1073-1084. 2016
- 4 risk assessment models had good calibration but poor discrimination for VTE in hospitalized medical patients. ACP journal club. 165:JC35-JC35. 2016
- Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. New England Journal of Medicine. 375:534-544. 2016
- Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. Journal of Thrombosis and Haemostasis. 14:875-885. 2016
- Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism. Blood. 127:2035-2037. 2016
- Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem. Journal of Thoracic and Cardiovascular Surgery. 151:992-999. 2016
- Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF. ACP journal club. 164:JC33-JC33. 2016
- Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study. Journal of Thrombosis and Haemostasis. 14:504-509. 2016
- Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial. Thrombosis Research. 139:77-81. 2016
- Catheter-directed thrombolysis for extensive iliofemoral deep vein thrombosis: review of literature and ongoing trials. Expert Review of Cardiovascular Therapy. 14:189-200. 2016
- Bridging Anticoagulation in Patients with Atrial Fibrillation. New England Journal of Medicine. 374:90-94. 2016
- Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure. Journal of Thrombosis and Haemostasis. 14:89-97. 2016
- Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. Journal of Thrombosis and Thrombolysis. 41:154-164. 2016
- Periprocedural Management of Direct Oral Anticoagulants. Regional Anesthesia and Pain Medicine. 41:127-129. 2016
- Analysis of an algorithm incorporating limited and whole-leg assessment of the deep venous system in symptomatic outpatients with suspected deep-vein thrombosis (PALLADIO): a prospective, multicentre, cohort study. The Lancet Haematology. 2:e474-e480. 2015
- How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society. ACP journal club. 163:382-385. 2015
- Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. New England Journal of Medicine. 373:823-833. 2015
- Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials. Polskie Archiwum Medycyny Wewnetrznej. 125:666-671. 2015
- Screening for Occult Cancer in Unprovoked Venous Thromboembolism. New England Journal of Medicine. 373:697-704. 2015
- Perioperative Management of Dabigatran. Circulation. 132:167-173. 2015
- Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures. JAMA Internal Medicine. 175:1163-1163. 2015
- New oral anticoagulants versus vitamin K antagonists for treatment of acute venous thromboembolism: do they really increase the incidence of myocardial infarction?. Internal and emergency medicine. 10:493-498. 2015
- Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Thrombosis and Haemostasis. 113:625-632. 2015
- Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data. Journal of Thrombosis and Haemostasis. 13:775-781. 2015
- Perioperative anticoagulation—are we at 'a bridge too far'?. Nature Reviews Cardiology. 12:133-134. 2015
- Real‐world variability in dabigatran levels in patients with atrial fibrillation. Journal of Thrombosis and Haemostasis. 13:353-359. 2015
- Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review. Canadian Journal of Anaesthesia. 62:194-202. 2015
-
d -Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy. ACP journal club. 162:27-34. 2015 - Well-managed warfarin is superior to NOACs Response. Canadian Family Physician. 61:24-25. 2015
- Direct Oral Anticoagulants. JACC: Cardiovascular Interventions. 7:1333-1351. 2014
- Approach to the new oral anticoagulants in family practice: part 1: comparing the options.. Canadian Family Physician. 60:989-995. 2014
- Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.. Canadian Family Physician. 60:997-1001. 2014
- Guidance, guidelines, and communications. Journal of Thrombosis and Haemostasis. 12:1744-1745. 2014
- Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial. Thrombosis Research. 134:814-818. 2014
- Factors that predict thrombosis in relatives of patients with venous thromboembolism. Blood. 124:2124-2130. 2014
- Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials. Journal of Thrombosis and Haemostasis. 12:1419-1424. 2014
- Portal Vein Thrombosis. Clinical and Applied Thrombosis/Hemostasis. 20:498-506. 2014
- Unusual venous thrombosis. CANADIAN MEDICAL ASSOCIATION JOURNAL. 186:697.3-698. 2014
- Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation. Circulation. 129:1850-1859. 2014
- Response. Chest. 145:1174-1175. 2014
- New oral anticoagulants and oculoplastic surgery. Canadian Journal of Ophthalmology. 49:123-127. 2014
- Ruling out DVT using the Wells rule and a D-dimer test. The BMJ. 348:g1637-g1637. 2014
- Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis. Thrombosis and Haemostasis. 111:172-179. 2014
- Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery. Chest. 144:1848-1856. 2013
- Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implementation Science. 8:1. 2013
- Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials. Polskie Archiwum Medycyny Wewnetrznej. 123:617-622. 2013
- Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy. Canadian Journal of Cardiology. 29:1334-1345. 2013
- Device Surgery without Interruption of Anticoagulation. New England Journal of Medicine. 369:1570-1572. 2013
- Device surgery without interruption of anticoagulation.. New England Journal of Medicine. 369:1570-1571. 2013
- Interruption of Warfarin Anticoagulation for Dental Surgery: Response. Chest. 144:1424-1426. 2013
- Secondary prevention of venous thromboembolism. The BMJ. 347:f5440-f5440. 2013
- Perioperative management of patients who are receiving a novel oral anticoagulant. Internal and emergency medicine. 8:477-484. 2013
- Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 11:1593-1596. 2013
- Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting. Anesthesiology. 118:1466-1474. 2013
- Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach. Current Treatment Options in Cardiovascular Medicine. 15:224-239. 2013
- Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences. Journal of Clinical Epidemiology. 66:415-425. 2013
- Response to Letters Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. Circulation. 127:E506-E506. 2013
- Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging. CANADIAN MEDICAL ASSOCIATION JOURNAL. 185:E194-E200. 2013
- Initial and long-term treatment of deep venous thrombosis: recent clinical trials and their impact on patient management. Expert Opinion on Pharmacotherapy. 14:385-396. 2013
-
Selective
d -Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis. ACP journal club. 158:93-93. 2013 - Accuracy of emergency physician–performed ultrasonography in the diagnosis of deep-vein thrombosis. Thrombosis and Haemostasis. 109:137-145. 2013
- Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Critical Care. 17:230-230. 2013
- Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?. Journal of Thrombosis and Haemostasis. 10:2621-2624. 2012
- How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood. 120:2954-2962. 2012
- Management of Bleeding in Patients Receiving Conventional or New Anticoagulants. Drugs. 72:1965-1975. 2012
- Perioperative Management of Patients Having Noncardiac Surgery Who Are Receiving Anticoagulant or Antiplatelet Therapy: An Evidence-Based but Practical Approach. Seminars in Thrombosis and Hemostasis. 38:652-660. 2012
- Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists. Circulation. 126:1630-1639. 2012
- Management of patients who are receiving warfarin or a new oral anticoagulant and require urgent or emergency surgery. Polskie Archiwum Medycyny Wewnetrznej. 122:437-442. 2012
- Accuracy and safety of 99mTc-labeled anti-D-dimer (DI-80B3) Fab’ fragments (ThromboView®) in the diagnosis of deep vein thrombosis: A phase II study. Thrombosis Research. 130:381-389. 2012
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin. Circulation. 126:343-348. 2012
- Erratum. American Journal of Hematology. 87:748-748. 2012
- Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). Journal of Thrombosis and Haemostasis. 10:1019-1025. 2012
- Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. American Journal of Hematology. 87:S141-S145. 2012
- Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 10:698-702. 2012
- Perioperative Management of Antithrombotic Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (vol 141, pg e326S, 2012). Chest. 141:1129-1129. 2012
- Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. Journal of Thrombosis and Haemostasis. 10:692-694. 2012
- Bridging Anticoagulation. Circulation. 125:e496-e498. 2012
- Perioperative Management of Antithrombotic Therapy. Chest. 141:e326S-e350S. 2012
- Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis. Journal of the American Medical Association (JAMA). 307:294-303. 2012
- Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: A survey of healthcare professionals. Journal of Hospital Medicine. 7:28-34. 2012
- Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery”. Thrombosis and Haemostasis. 108:210-212. 2012
- Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence‑based and practical approach. Polskie Archiwum Medycyny Wewnetrznej. 118:209-215. 2012
- Statins and Intracerebral Hemorrhage. Circulation. 124:2233-2242. 2011
- The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy. Clinical and Applied Thrombosis/Hemostasis. 17:E106-E113. 2011
- Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach. Hospital Practice. 39:41-53. 2011
- Detection of Pulmonary Emboli With 99mTc-Labeled Anti–D-dimer (DI-80B3)Fab′ Fragments (ThromboView). American Journal of Respiratory and Critical Care Medicine. 184:708-714. 2011
- Erratam. Canadian Journal of Cardiology. 27:663-663. 2011
- The association between venous thromboembolism and physical inactivity in everyday life. The BMJ. 343:d3865-d3865. 2011
- Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?. Thrombosis Research. 127:513-517. 2011
- ACP journal club. Apixaban reduced VTE and did not increase major bleeding compared with enoxaparin in hip replacement.. ACP journal club. 154:JC5-J06. 2011
- Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment. ACP journal club. 154:JC5-JC5. 2011
- Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach. Blood. 117:5044-5049. 2011
- Assessment of Recurrence Risk After Unprovoked Venous Thromboembolism. ACP journal club. 154:644-644. 2011
- The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines. Canadian Journal of Cardiology. 27:S1-S59. 2011
- The clinical impact of bleeding during oral anticoagulant therapy. Journal of Thrombosis and Thrombolysis. 31:419-423. 2011
- Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management. Polskie Archiwum Medycyny Wewnetrznej. 121:73-80. 2011
- The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary. Canadian Journal of Cardiology. 27:208-221. 2011
- Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. The BMJ. 342:d813-d813. 2011
- Review: Positive D-dimer results predict recurrence after first unprovoked VTE regardless of test timing or cutpoint, or patient age. ACP journal club. 154:JC1-JC1. 2011
- Deep Vein Thrombosis Prophylaxis in Hospitalized Medical Patients: Current Recommendations, General Rates of Implementation, and Initiatives for Improvement. Clinics in Chest Medicine. 31:675-689. 2010
- Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis. Journal of Thrombosis and Haemostasis. 8:2436-2442. 2010
-
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of
d -Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism. ACP journal club. 153:523-523. 2010 - Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management. Current Pharmaceutical Design. 16:3436-3441. 2010
- Safety of Uninterrupted Anticoagulation in Patients Requiring Elective Coronary Angiography With or Without Percutaneous Coronary Intervention. Chest. 138:840-847. 2010
- Prevention and Treatment of Hormone-Associated Venous Thromboembolism: A Patient Management Approach. Hematology/Oncology Clinics of North America. 24:683-694. 2010
- The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. Journal of Critical Care. 25:287-293. 2010
- Risk of stroke after surgery in patients with and without chronic atrial fibrillation. Journal of Thrombosis and Haemostasis. 8:884-890. 2010
- The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months. Journal of Thrombosis and Haemostasis. 8:1126-1127. 2010
- Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: A retrospective chart review. Thrombosis Research. 125:351-352. 2010
- Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?. Journal of Thrombosis and Haemostasis. 8:496-498. 2010
- Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound. Journal of the American Medical Association (JAMA). 303:438-438. 2010
- Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?. Journal of Thrombosis and Thrombolysis. 29:208-213. 2010
- Preventing venous thromboembolism in long-term care residents: Cautious advice based on limited data. Cleveland Clinic Journal of Medicine. 77:123-130. 2010
- Evidence and clinical judgment: Treatment of cerebral vein thrombosis. Thrombosis and Haemostasis. 103:1109-1115. 2010
- Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis.. Texas dental journal. 126:1183-1193. 2009
- Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism. Chest. 136:1537-1545. 2009
- Perioperative management of antithrombotic therapy: lifting the fog. Journal of Thrombosis and Haemostasis. 7:1979-1981. 2009
- Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial. Journal of Thrombosis and Thrombolysis. 28:269-269. 2009
- Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial. Journal of Thrombosis and Thrombolysis. 28:266-268. 2009
- Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Current Opinion in Pulmonary Medicine. 15:455-462. 2009
- Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. American Journal of Hematology. 84:584-588. 2009
- 2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients. Polskie Archiwum Medycyny Wewnetrznej. 119:541-549. 2009
- The devil is in the details...or not? A primer on individual patient data meta-analysis. BMJ Evidence-Based Medicine. 14:100-101. 2009
- The devil is in the details...or not? a primer on individual patient data meta-analysis. Annals of Internal Medicine. 151. 2009
- The devil is in the details…or not? A primer on individual patient data meta-analysis. ACP journal club. 151:JC1-JC1. 2009
- Safety of continuing warfarin therapy during cataract surgery: A systematic review and meta-analysis. Thrombosis Research. 124:292-299. 2009
- Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis. Journal of Critical Care. 24:168-175. 2009
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation. New England Journal of Medicine. 360:2066-2078. 2009
- Thromboprophylaxis for hospitalized medical patients: A Multicenter Qualitative study. Journal of Hospital Medicine. 4:269-275. 2009
- The long-term risk of cancer in patients with a first episode of venous thromboembolism. Journal of Thrombosis and Haemostasis. 7:546-551. 2009
- Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials. Thrombosis Research. 123:687-696. 2009
- Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis.. Journal of the Canadian Dental Association. 75:41. 2009
-
Systematic Review:
d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism. ACP journal club. 149:481-481. 2008 - Industry funding and the reporting quality of large long-term weight loss trials. International Journal of Obesity. 32:1531-1536. 2008
- Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry). American Journal of Cardiology. 102:883-889. 2008
- Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. Journal of Thrombosis and Haemostasis. 6:1615-1621. 2008
- Why A-level evidence does not make it to clinicians' A-list: the case of thromboprophylaxis in medical patients. BMJ Evidence-Based Medicine. 13:133-134. 2008
- Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>. JAMA Internal Medicine. 168:1805-1805. 2008
- Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions. Current Opinion in Pulmonary Medicine. 14:381-388. 2008
- Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients. ACP journal club. 149:JC2-JC2. 2008
- Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients.. ACP journal club. 149:2. 2008
- Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.. International Angiology. 27:333-343. 2008
- Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question. Mayo Clinic proceedings. 83:628-629. 2008
- The Perioperative Management of Antithrombotic Therapy. Chest. 133:299S-339S. 2008
- Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 6:405-414. 2008
- Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. Journal of Thoracic and Cardiovascular Surgery. 135:705-706. 2008
- Perioperative management of antithrombotic therapy. Polskie Archiwum Medycyny Wewnetrznej. 118:201-208. 2008
- Patient Outcomes After Deep Vein Thrombosis and Pulmonary Embolism<subtitle>The Worcester Venous Thromboembolism Study</subtitle>. JAMA Internal Medicine. 168:425-425. 2008
- Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials. Thrombosis Research. 123:24-34. 2008
- Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice. Thrombosis Research. 122:864-866. 2008
- Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors. Critical Care. 12:R32-R32. 2008
- The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism. ACP journal club. 147:766-766. 2007
- Are heparins anti-neoplastic agents?. Polskie Archiwum Medycyny Wewnetrznej. 117:491-493. 2007
- Anticoagulant Prophylaxis for Hospitalized Medical Patients. ACP journal club. 147:524-524. 2007
- In response. Annals of Internal Medicine. 147:524. 2007
- The management of anticoagulated patients requiring dental extraction: a cross‐sectional survey of oral and maxillofacial surgeons and hematologists. Journal of Thrombosis and Haemostasis. 5:2157-2159. 2007
- What is the quality of reporting in weight loss intervention studies? A systematic review of randomized controlled trials. International Journal of Obesity. 31:1554-1559. 2007
- Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. Journal of Thrombosis and Thrombolysis. 24:93-97. 2007
- Anticoagulation therapy in patients with prosthetic heart valves.. Clinical Advances in Hematology and Oncology. 5:436-438. 2007
- Should you add aspirin to your heart patient's warfarin regimen?. Journal of Family Practice. 56:430. 2007
- 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CANADIAN MEDICAL ASSOCIATION JOURNAL. 176:S1-S13. 2007
- Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?. American Journal of Medicine. 120:369.e9-369.e14. 2007
- Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients. ACP journal club. 146:278-278. 2007
- Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease. JAMA Internal Medicine. 167:117-117. 2007
- Non-surgical treatment of obesity: Canadian Task Force on Preventive Health Care recommendation statement. Canadian Family Physician. 52:1576-1578. 2006
- DHCR7 mutation carrier rates and prevalence of the RSH/Smith‐Lemli‐Opitz syndrome: Where are the patients?. American Journal of Medical Genetics, Part A. 140A:2057-2062. 2006
- Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism. Journal of the American Medical Association (JAMA). 296:935-935. 2006
- Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial. Annals of Pharmacotherapy. 40:1241-1247. 2006
- The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians. Internal and emergency medicine. 1:96-104. 2006
-
An Evaluation of
d -Dimer in the Diagnosis of Pulmonary Embolism. ACP journal club. 144:812-812. 2006 - Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry. Journal of Thrombosis and Haemostasis. 4:1246-1252. 2006
- Self-monitoring and self-dosing of oral anticoagulation improves survival. Evidence-based Cardiovascular Medicine. 10:124-126. 2006
- Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin. JAMA Internal Medicine. 166:853-853. 2006
- Managing anticoagulant and antiplatelet drugs in patients who are receiving neuraxial anesthesia and epidural analgesia: a practical guide for clinicians. Techniques in Regional Anesthesia and Pain Management. 10:46-55. 2006
- Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. Journal of Thrombosis and Haemostasis. 4:552-556. 2006
- Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency. Thrombosis Research. 118:409-416. 2006
- Managing thromboembolism and bleeding in patients with impaired renal function: A common but under-recognized clinical problem. Thrombosis Research. 118:381-383. 2006
- The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: Assessment of a standardized patient management protocol. Thrombosis and Haemostasis. 96:387-389. 2006
- Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency. Journal of Critical Care. 20:324-329. 2005
- Hormone replacement therapy and risk for venous thromboembolism: what??s new and how do these findings influence clinical practice?. Current Opinion in Hematology. 4:649-654. 2005
- The diagnosis of deep venous thrombosis and pulmonary embolism in medical-surgical intensive care unit patients. Journal of Critical Care. 20:314-319. 2005
- Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. International Journal of Obesity. 29:1153-1167. 2005
- Management of hypertension in overweight and obese patients: A practical guide for clinicians. Current Hypertension Reports. 7:330-336. 2005
- Use of a Clinical Prediction Score in Patients with Suspected Deep Venous Thrombosis: Two Steps Forward, One Step Back?. ACP journal club. 143:140-140. 2005
- Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials. Annals of Pharmacotherapy. 39:1188-1193. 2005
- Dose Capping Enoxaparin Is Unjustified and Denies Patients With Acute Coronary Syndromes a Potentially Effective Treatment. Chest. 127:2288-2289. 2005
- Systematic Overview of Warfarin and Its Drug and Food Interactions. JAMA Internal Medicine. 165:1095-1095. 2005
- Body weight classification. CANADIAN MEDICAL ASSOCIATION JOURNAL. 172:1274-1275. 2005
- Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study. Journal of Thrombosis and Haemostasis. 3:943-948. 2005
- Dose–response study of recombinant human soluble thrombomodulin (ART‐123) in the prevention of venous thromboembolism after total hip replacement. Journal of Thrombosis and Haemostasis. 3:962-968. 2005
- Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial. Annals of Pharmacotherapy. 39:840-842. 2005
- Nontreatment of deep vein thrombosis - Response. Canadian Family Physician. 51:654-655. 2005
- Nontreatment of deep vein thrombosis.. Canadian Family Physician. 51:654. 2005
- Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CANADIAN MEDICAL ASSOCIATION JOURNAL. 172:995-998. 2005
-
A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis:
d -Dimer Testing Compared with Repeated Ultrasonography. ACP journal club. 142:490-490. 2005 - Using low molecular weight heparins as "bridging anticoagulant therapy". Journal of Respiratory Diseases. 26:170-172. 2005
- The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism. Journal of Thrombosis and Haemostasis. 3:508-513. 2005
- Obesity and Cardiovascular Disease: Pathogenic Mechanisms and Potential Benefits of Weight Reduction. Seminars in Thrombosis and Hemostasis. 5:25-33. 2005
- Treatment of deep vein thrombosis: what factors determine appropriate treatment?. Canadian Family Physician. 51:217-223. 2005
- Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.. Journal of Population Therapeutics and Clinical Pharmacology. 12:e229-e239. 2005
- Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Thrombosis and Haemostasis. 94:528-531. 2005
- Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.. Haematologica. 90:137-139. 2005
- Perioperative Anticoagulation for Patients with Mechanical Heart Valves: A Survey of Current Practice. Journal of Thrombosis and Thrombolysis. 18:199-203. 2004
- Incidence of Smith-Lemli-Opitz syndrome in Canada: Results of three-year population surveillance. Journal of Pediatrics. 145:530-535. 2004
- Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin. Circulation. 110:1658-1663. 2004
- Review: counselling, pharmacotherapy, and surgery help obese adults lose weight. BMJ Evidence-Based Medicine. 9:110-110. 2004
- Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin. JAMA Internal Medicine. 164:1319-1319. 2004
- Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis. 2:743-749. 2004
- Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome. Chest. 125:1616-1621. 2004
- Major bleeding risk with warfarin for deep vein thrombosis.. Cleveland Clinic Journal of Medicine. 71:282-282. 2004
- Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thrombosis Research. 114:161-165. 2004
- The Management of Hypertension in the Overweight and Obese Patient. Drugs. 64:1264-1265. 2004
- The Management of Hypertension in the Overweight and Obese Patient. Drugs. 64:1263-1263. 2004
- The Management of Hypertension in the Overweight and Obese Patient. Drugs. 64:795-803. 2004
- Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism. ACP journal club. 139:893-893. 2003
- Opinions in pediatric and adolescent gynecology. Journal of Pediatric and Adolescent Gynecology. 16:377-379. 2003
- A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome. New England Journal of Medicine. 349:1133-1138. 2003
- Therapy for DVT: The importance of the thrombus site. Journal of Respiratory Diseases. 24. 2003
- Preventing DVT: Is short-duration prophylaxis effictive?. Journal of Critical Illness. 18:148-149. 2003
- Epidural analgesia for pain relief following hip or knee replacement. Clinical Respiratory Journal. 2014:CD003071. 2003
- Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thrombosis Research. 108:3-13. 2002
- Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy. ACP journal club. 137:251-251. 2002
- Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement. JAMA Internal Medicine. 162:1465-1465. 2002
- Elevated Cardiac Troponin Levels in Patients With Submassive Pulmonary Embolism. JAMA Internal Medicine. 162:79-79. 2002
- Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery. Thrombosis and Haemostasis. 88:37-40. 2002
- Identifying patients at increased risk for recurrent venous thromboembolism: Clinical, biochemical, and radiologic risk factors. Cardiovascular Reviews and Reports. 23:280-285+291. 2002
- Treatment of Warfarin-Associated Coagulopathy. Chest. 120:1972-1976. 2001
- Prognosis in pulmonary embolism. Current Opinion in Pulmonary Medicine. 7:354-359. 2001
-
Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and
d -dimer Testing. ACP journal club. 135:108-108. 2001 - Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. The Lancet. 358:9-15. 2001
- Deep Vein Thrombosis and Its Prevention in Critically Ill Adults. JAMA Internal Medicine. 161:1268-1268. 2001
- Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/. American Journal of Medicine. 110:515-519. 2001
- Commentary. Western Journal of Medicine. 174:256-256. 2001
- Review: current oral contraceptive use increases the risk for ischaemic stroke. BMJ Evidence-Based Medicine. 6:60-60. 2001
- Acute Renal Vein Thrombosis, Oral Contraceptive Use, and Hyperhomocysteinemia. Mayo Clinic proceedings. 76:212-214. 2001
- Patient Self-Monitoring of Oral Anticoagulant Therapy. American Journal of Cardiovascular Drugs. 1:245-251. 2001
- Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy. JAMA Internal Medicine. 160:3431-3431. 2000
- Effect of hormone replacement therapy on the endogenous thrombin potential. Blood. 96. 2000
- Endogenous thrombin potential and the risk of venous thromboembolism. Blood. 96. 2000
- Use of vitamin k to reverse warfarin-induced excessive anticoagulation: a survey of current practice habits. Blood. 96. 2000
- Treatment of Proximal Deep Vein Thrombosis With a Novel Synthetic Compound (SR90107A/ORG31540) With Pure Anti–Factor Xa Activity. Circulation. 102:2726-2731. 2000
- Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. The Lancet. 356:1551-1553. 2000
- The Effects of Hormone Replacement Therapy on Thrombin Generation, Fibrinolysis Inhibition, and Resistance to Activated Protein C. Thrombosis Research. 99:25-34. 2000
- A negative D-dimer result and low risk clinical status effectively ruled out DVT in symptomatic patients. BMJ Evidence-Based Medicine. 5:92-92. 2000
- Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.. Canadian Journal of Cardiology. 16:326-330. 2000
- A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism. JAMA Internal Medicine. 160:181-181. 2000
- Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery. Chest. 116:1240-1246. 1999
- Understanding obesity.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 160:1820-1821. 1999
- Incorporating preventive care recommendations into clinical practice: how do we bridge the gap?. CANADIAN MEDICAL ASSOCIATION JOURNAL. 160:1171-1172. 1999
- Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. CANADIAN MEDICAL ASSOCIATION JOURNAL. 160:513-525. 1999
- Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 160:513-525. 1999
- The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus. Thrombosis and Haemostasis. 82:1028-1032. 1999
- Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy. Thrombosis Research. 92:11-17. 1998
- Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism. Journal of the American Medical Association (JAMA). 279:458-458. 1998
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism. New England Journal of Medicine. 337:657-662. 1997
- A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. JAMA Internal Medicine. 157:1522-1530. 1997
- The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. JAMA Internal Medicine. 157:1077-1081. 1997
- The Clinical Utility of a Rapid Bedside D-dimer Assay for Screening of Deep Vein Thrombosis following Orthopaedic Surgery. Thrombosis and Haemostasis. 78:1300-1301. 1997
- Uterine vein thrombosis: an unusual variant of pelvic vein thrombophlebitis. Journal of Obstetrics and Gynaecology. 17:106-107. 1997
- Diagnosis of deep vein thrombosis.. Canadian Family Physician. 42:497-503. 1996
- Evaluation of a Soluble Fibrin Assay in Patients with Suspected Pulmonary Embolism. Thrombosis and Haemostasis. 75:551-554. 1996
- The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density. Thrombosis and Haemostasis. 75:254-257. 1996
- Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis.. Thrombosis and Haemostasis. 74:833-836. 1995
- A Novel and Rapid Whole-Blood Assay for D-Dimer in Patients With Clinically Suspected Deep Vein Thrombosis. Circulation. 91:2184-2187. 1995
- Diagnostic Problems with Venous Thromboembolic Disease in Pregnancy. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 25:58-71. 1995
- Familial testicular cancer. What role does heredity play?. Canadian Family Physician. 39:1640-1641. 1993
- Miliary pulmonary cryptococcosis in a patient with the acquired immunodeficiency syndrome.. Thorax. 48:402-403. 1993
- Campylobacter fetus cholangitis and bacteremia.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 141:925-926. 1989